NZ$37.86
0.16%
New Zealand Exchange, Wed, Dec 24 2025
ISIN
NZFAPE0001S2
Symbol
FPH

Fisher & Paykel Healthcare Stock price

NZ$37.86
+0.58 1.56% 1M
+1.64 4.53% 6M
-0.46 1.20% YTD
-0.40 1.05% 1Y
+15.97 72.96% 3Y
+4.29 12.79% 5Y
+29.57 356.62% 10Y
+35.48 1,490.09% 20Y
New Zealand Exchange, Closing price Wed, Dec 24 2025
+0.06 0.16%
ISIN
NZFAPE0001S2
Symbol
FPH

Key metrics

Basic
Market capitalization
NZ$22.3b
Enterprise Value
NZ$22.1b
Net debt
positive
Cash
NZ$300.0m
Shares outstanding
587.3m
Valuation (TTM | estimate)
P/E
51.2 | 49.2
P/S
10.3 | 9.8
EV/Sales
10.2 | 9.7
EV/FCF
48.9
P/B
11.2
Dividends
DPS
NZ$0.67
Yield 1Y | 5Y
1.6% | 2.0%
Growth 1Y | 5Y
2.6% | 6.7%
Payout 1Y | 3Y
102.5% | 147.4%
Increased
8 Years
Financials (TTM | estimate)
Revenue
NZ$2.2b | NZ$2.3b
EBITDA
- | NZ$755.7m
EBIT
NZ$577.6m | NZ$611.8m
Net Income
NZ$437.0m | NZ$451.9m
Free Cash Flow
NZ$451.7m
Growth (TTM | estimate)
Revenue
14.2% | 12.8%
EBITDA
- | -
EBIT
80.0% | 20.1%
Net Income
144.8% | 19.8%
Free Cash Flow
16.6%
Margin (TTM | estimate)
Gross
63.4%
EBITDA
- | 33.2%
EBIT
26.8%
Net
20.3% | 19.8%
Free Cash Flow
20.9%
Financial Health
Equity Ratio
74.1%
Return on Equity
20.0%
ROCE
26.7%
ROIC
22.3%
Debt/Equity
0.1
More
EPS
NZ$0.7
FCF per Share
NZ$0.8
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Fisher & Paykel Healthcare a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Fisher & Paykel Healthcare Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Fisher & Paykel Healthcare forecast:

6x Buy
40%
7x Hold
47%
2x Sell
13%

Analyst Opinions

15 Analysts have issued a Fisher & Paykel Healthcare forecast:

Buy
40%
Hold
47%
Sell
13%

Financial data from Fisher & Paykel Healthcare

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,158 2,158
14% 14%
100%
- Direct Costs 790 790
6% 6%
37%
1,368 1,368
19% 19%
63%
- Selling and Administrative Expenses 559 559
8% 8%
26%
- Research and Development Expense 231 231
9% 9%
11%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 578 578
80% 80%
27%
Net Profit 437 437
145% 145%
20%

In millions NZD.

Don't miss a Thing! We will send you all news about Fisher & Paykel Healthcare directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. The firm provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. The company operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.

Head office New Zealand
Website www.fphcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today